Eradigm Consulting
Kamaal Joins Eradigm as an associate consultant bringing experience in psychiatric disorder treatment research and a desire to improve drug discovery pipelines.
He holds a BSc in Pharmacology from UCL where his passion for the translation of preclinical research to life-changing clinical therapies was initiated. During his degree, he conducted a research project where he screened BK channel activating drugs on the voltage dependence of BK channels using patch-clamp techniques. He was part of a team of pharmacologists and bioscientists investigating these BK channel properties for insights into respiratory diseases and potential treatments.
During his studies, Kamaal worked as a Covid-19 testing assistant in the UCL testing site where he gained a unique first-hand perspective of the impact of the global pandemic.
In between his studies, Kamaal solely produced and released a report on the most novel antidepressant and anxiolytic drugs in phase II clinical trials or later for the mental health charity Overcome, as an intern. This report was a part of the charity’s initiatives focused on providing accessible and free solutions globally for psychiatric disorders. As a business development intern for FlowCell Kamaal got to grips with the needs of end-users in the neuroscience field by liaising with potential clients to build customer profiles.
Outside of work, Kamaal is a keen fitness enthusiast playing American football competitively and being an avid gym-goer. He has a passion for Sci-Fi/fantasy books and films with his current favourite being the Dune book series by Frank Herbert due to its expansive story and philosophical overtones.
This person is not in any teams
Eradigm Consulting
2 followers
Eradigm works with select biopharmaceutical companies to develop a deeper and more nuanced understanding of their markets. We focus on informing and shaping high impact strategies for your product or portfolio, whatever its stage in the clinical or commercial life-cycle. Our core expertise is built on decades of experience in the pharmaceutical sector, giving us the ability to deliver value to our clients at the intersection of three key industry dynamics: the ever increasing value imperative, shrinking sources of true competitive advantage and cutting edge therapeutic innovation. Our founding team’s experience spans more than 30 years both leading and supporting the development and commercialisation of some of the world’s most lucrative and innovative biopharmaceutical products.